Disclaimer: This compound is sold for in vitro research and educational purposes only
Key Findings from Preclinical Research Insights from Animal Studies While we always look to human trials for definitive answers, preclinical research offers a powerful window into how a compound works
After sanitizing, your clinician will use their thumb and forefinger to hold the skin tight and administer the shot
Im a new customer/patient and a practicing physician

Get the Injury, Joint & Recovery Blueprint *Educational only No protocols Written by clinicians* When to Use BPC-157 + TB-500 This blend is ideal for a range of patients and scenarios, including: Athletes looking to recover from training faster Post-surgical patients needing accelerated healing Individuals with tendinopathy , ligament sprains , or joint instability Chronic pain sufferers seeking regenerative alternatives Patients with gut inflammation or leaky gut (BPC-157 has GI-healing properties) People with connective tissue disorders or injury-prone joints Individuals experiencing inflammatory joint conditions (such as arthritis) Expected Results While every patient responds differently, many experience: Reduced pain and inflammation within 12 weeks Enhanced range of motion and tissue resilience Accelerated recovery time from injuries or surgeries Improved mobility and flexibility Reduced gut permeability and inflammation (via BPC-157) Peak results are typically seen 48 weeks into therapy, depending on severity and dosing

Instead of going deep into the muscle, this shot is delivered into the fatty tissue just under the skins surface, often in the abdomen or the outer part of the thigh